Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Atif Zaman, Eugene R. Schiff et al.|Gastroenterology|2015Cited by 799
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus InfectionKimberly Workowski, Raymond T. Chung, Marc G. Ghany et al.|Clinical Infectious Diseases|2018Cited by 726
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1Thomas Boyer, Howard Monsour, Arun J. Sanyal et al.|Gastroenterology|2016Cited by 305
NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosisJacqueline G. O’Leary, Jasmohan S. Bajaj, K. Rajender Reddy et al.|Hepatology|2018Cited by 270
The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosisJasmohan S. Bajaj, Jacqueline G. O’Leary, K. Rajender Reddy et al.|Hepatology|2015Cited by 237